Hsbc Holdings PLC Has $641,000 Stock Position in Envista Holdings Corporation $NVST

Hsbc Holdings PLC lowered its stake in Envista Holdings Corporation (NYSE:NVST) by 69.4% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 25,528 shares of the company’s stock after selling 57,822 shares during the period. Hsbc Holdings PLC’s holdings in Envista were worth $641,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of NVST. Caitong International Asset Management Co. Ltd lifted its position in Envista by 16,711.1% during the third quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock worth $31,000 after purchasing an additional 1,504 shares during the period. Allworth Financial LP increased its holdings in Envista by 75.4% in the 4th quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock valued at $39,000 after buying an additional 776 shares during the period. UMB Bank n.a. increased its holdings in Envista by 46.1% in the 4th quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock valued at $44,000 after buying an additional 636 shares during the period. IFP Advisors Inc raised its position in shares of Envista by 102.9% in the 4th quarter. IFP Advisors Inc now owns 2,112 shares of the company’s stock valued at $46,000 after buying an additional 1,071 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Envista by 73.1% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock valued at $44,000 after buying an additional 949 shares in the last quarter.

Analyst Ratings Changes

Several research firms recently issued reports on NVST. Morgan Stanley increased their price target on shares of Envista from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Friday, April 24th. Weiss Ratings downgraded shares of Envista from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, May 11th. Wall Street Zen cut Envista from a “strong-buy” rating to a “buy” rating in a research note on Saturday, May 9th. JPMorgan Chase & Co. raised their target price on Envista from $26.00 to $29.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Finally, Zacks Research lowered Envista from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 6th. Six investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $28.62.

Envista Stock Down 2.0%

NVST stock opened at $27.80 on Friday. The firm has a 50-day moving average price of $25.52 and a 200-day moving average price of $25.88. Envista Holdings Corporation has a 12 month low of $18.77 and a 12 month high of $30.42. The company has a current ratio of 2.44, a quick ratio of 2.06 and a debt-to-equity ratio of 0.47. The stock has a market capitalization of $4.52 billion, a P/E ratio of 67.81, a price-to-earnings-growth ratio of 1.61 and a beta of 0.86.

Envista (NYSE:NVST) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.05. The company had revenue of $705.50 million for the quarter, compared to analyst estimates of $680.03 million. Envista had a net margin of 2.41% and a return on equity of 7.11%. The firm’s revenue was up 14.4% on a year-over-year basis. During the same period in the previous year, the firm posted $0.24 EPS. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. As a group, equities research analysts anticipate that Envista Holdings Corporation will post 1.42 EPS for the current fiscal year.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.